X
Change at the top at Adaptimmune as Noble stands down
https://pharmaphorum.com/news/change-at-the-top-at-adaptimmune-as-noble-stands-down/
TCR
Kite outlines vision for next gen cancer killing cells
Backed by Amgen, Kite outlines bold plan for developing CAR-T and TCR cells.